β¨ Education and Health Notices
NEW ZEALAND GAZETTE
No. 37
Cancellation of Licence for an Early Childhood Centre
Pursuant to Regulation 12 (1) (d) (i) of the Education (Early Childhood Centres) Regulations 1998, and acting under authority delegated by the Secretary for Education, I hereby cancel the licence dated 28 March 1995, which was granted under those Regulations to Susan Cameron, in respect of Te Karaka Playcentre (55019), situated at 10 Apa Street, Te Karaka, Gisborne.
This notice shall take effect the day after the date of its notification in the New Zealand Gazette.
CLAIRE DOUGLAS, Acting Group Manager.
go2568
Cancellation of Licence for an Early Childhood Centre
Pursuant to Regulation 12 (1) (d) (i) of the Education (Early Childhood Centres) Regulations 1998, and acting under authority delegated by the Secretary for Education, I hereby cancel the licence dated 1 February 1995, which was granted under those Regulations to Christine Finnigan, in respect of Waipawa Playcentre (55293), situated at Kenilworth Street, Waipawa.
This notice shall take effect the day after the date of its notification in the New Zealand Gazette.
CLAIRE DOUGLAS, Acting Group Manager.
go2567
Health
Medicines Act 1981
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Taxotere
Active Ingredient:
Docetaxel (trihydrate) 40mg/mL
Dosage Form:
Solution for concentrate for infusion
New Zealand Sponsor:
Aventis Pharma Limited
Manufacturer(s):
Aventis Pharma Specialites, Vitry-Sur-Seine, France
Aventis Pharma, Dagenham, Essex, United Kingdom
Note: This consent is valid for 2 years from 23 May 2002.
Dated this 12th day of April 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2598
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Paroxetine 20 mg
Active Ingredient:
Paroxetine mesylate 25.83mg equivalent to 20mg paroxetine base
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Synthon BV
Manufacturers:
Heumann Pharma GmbH, Feucht, Germany
Synthon Hispania SL, Sant Boi de Llobregat, Barcelona, Spain
Dated this 17th day of April 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2651
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Pariet
Active Ingredient:
Rabeprazole sodium 10mg equivalent to 9.42mg rabeprazole
Dosage Form:
Enteric coated tablet
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2002, No 37
Gazette.govt.nz —
NZ Gazette 2002, No 37
β¨ LLM interpretation of page content
π
Cancellation of Licence for an Early Childhood Centre
(continued from previous page)
π Education, Culture & ScienceEducation Regulations, Early Childhood Centre, Licence Cancellation
- Susan Cameron, Licence cancelled for Te Karaka Playcentre
- CLAIRE DOUGLAS, Acting Group Manager
π Cancellation of Licence for an Early Childhood Centre
π Education, Culture & ScienceEducation Regulations, Early Childhood Centre, Licence Cancellation
- Christine Finnigan, Licence cancelled for Waipawa Playcentre
- CLAIRE DOUGLAS, Acting Group Manager
π₯ Renewal of Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare12 April 2002
Medicines Act, Provisional Consent, Taxotere, Docetaxel
- G. R. BOYD, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare17 April 2002
Medicines Act, New Medicine, Paroxetine
- G. R. BOYD, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social WelfareMedicines Act, Changed Medicines, Pariet, Rabeprazole
- G. R. BOYD, Chief Advisor, Safety and Regulation